Key questions in the field of CD19 CAR T-cell therapy
Novel ALL treatment strategies: CAR T-cells
Accelerating assessment of therapies in hematology
A summary of lymphoma immune checkpoint inhibitor data at EHA 2017
Allogeneic transplant in multiple myeloma: who should receive it and the future of transplant
Heinz Ludwig et al.